ADORA2A and Parkinson disease: Initial studies on the psychomotor-activating effects of caffeine or selective A2AR antagonists dealt with general locomotor activity and were translationally applied to the treatment of akinesia in Parkinson’s disease (see above and Müller and Ferré, 2007; Morelli et al., 2009; Armentero et al., 2011).